UGM's COVID-19 Breathalyzer Test Gets Regulatory Approval

Translator

Antara

27 December 2020 11:13 WIB

TEMPO.CO, Jakarta - The Indonesian Health Ministry has granted a distribution license for ‘GeNose C19’, a diagnostic tool developed by researchers at Universitas Gadjah Mada (UGM) in Yogyakarta that uses breath analysis to detect COVID-19.

The regulator issued its permit on December 24, 2020, allowing the tool to be distributed, as it would help screen patients quickly, the research team’s leader, Professor Kuwat Triyana, said in a statement on Saturday.

With the license approved, the UGM team will begin distributing the first batch of ‘GeNose C19’ tests, which are being mass produced using funds from the State Intelligence Agency (BIN) and the Ministry of Research and Technology.

According to Triyana’s calculations, healthcare professionals will be able to conduct 120 tests per unit, with each test taking three minutes, including collection of breath samples of patients. With the first 100 units of ‘GeNose C19’ ready for release, about 12 thousand tests could be conducted in a day, he added.

"Thus, in one hour, we can have 20 people tested, and the tool can work for six hours, if it is used effectively," Triyana explained.

This figure for testing will likely be realized if the distribution is well managed, including at airports, trains stations, as well as other crowded spots such as hospitals, he pointed out.

“However, we are not only hoping for the increasing number [of tests], but we want more people infected with no symptoms to be found so they can receive treatment or [undergo] isolation; thus, COVID-19 transmission would be halted," he added.

A single ‘GeNose C19’ test will cost around Rp15-25 thousand (US$1-1.7). It will provide results in just two minutes, without requiring any reagents or other chemical instruments, Triyana said.

Also Read: Macron Tests Positive for COVID-19, European Leaders Rush for Tests

ANTARA



Merck Forecasts Drastic Slump in COVID-19 Drug Sales This Year

5 jam lalu

Merck Forecasts Drastic Slump in COVID-19 Drug Sales This Year

Merck & Co (MRK.N) on Thursday, Feb. 2, forecast a sharp decline in sales of its COVID-19 antiviral pill as the pandemic eases globally.


Second Booster for COVID-19 Not Required for Travel: Govt

3 hari lalu

Second Booster for COVID-19 Not Required for Travel: Govt

The Indonesian government continues to encourage its citizen to immediately get a second booster or the fourth dose of COVID-19 vaccine.


Minister Claims PeduliLindungi App Kept 626,000 Patients from Transmitting COVID-19

9 hari lalu

Minister Claims PeduliLindungi App Kept 626,000 Patients from Transmitting COVID-19

Health Minister Budi Gunadi Sadikin has claimed that the PeduliLindungi app prevent more than 626,000 positive patients from transmitting COVID-19.


Jakarta Rolls Out Second Booster for Covid-19 Starting Tomorrow

10 hari lalu

Jakarta Rolls Out Second Booster for Covid-19 Starting Tomorrow

The Jakarta Health Office will start rolling out the second booster or the fourth dose of Covid-19 vaccines starting Tuesday, January 24, 2023.


COVID-19: Jakarta Readies 300 Fourth Dose Vaccination Locations

11 hari lalu

COVID-19: Jakarta Readies 300 Fourth Dose Vaccination Locations

Jakarta Health Office prepared 300 vaccination locations to support provision of the fourth dose or second booster of COVID-19 vaccine to the public.


Quarantine Not Required for Chinese Tourists, Says Jokowi

13 hari lalu

Quarantine Not Required for Chinese Tourists, Says Jokowi

President Jokowi confirmed that the government did not enforce COVID-19 restrictions such as the mandatory quarantine for Chinese tourists.


Jokowi Opens Doors for Chinese Tourists as Immunity Rate Hits 98.5

13 hari lalu

Jokowi Opens Doors for Chinese Tourists as Immunity Rate Hits 98.5

Indonesia's President Jokowi said the country has opened its doors to foreign tourists, including China which is seeing a surge in COVID-19 cases.


China's COVID-19 Emergency Has Peaked, Official Says

19 hari lalu

China's COVID-19 Emergency Has Peaked, Official Says

Coronavirus fever and emergency hospitalizations have peaked in China and the number of hospitalized Covid-19 patients is continuing to decline.


2022 Car Sales Reach 1 Million Units, Up by 17.4 Percent

20 hari lalu

2022 Car Sales Reach 1 Million Units, Up by 17.4 Percent

Car sales in Indonesia have increased as the economic condition improved after the Covid-19 outbreak subsided


Yogyakarta Covid-19 Case Enters the Lowest Phase in Early 2023, Tourist Visits Decreasing

22 hari lalu

Yogyakarta Covid-19 Case Enters the Lowest Phase in Early 2023, Tourist Visits Decreasing

The new case of Covid-19 in the region of Yogyakarta in early January 2023 was recorded to have entered the lowest phase of its spreading.